Literature DB >> 15579038

Magnetic resonance imaging of cell surface receptors using targeted contrast agents.

Dmitri Artemov1, Zaver M Bhujwalla, Jeff W M Bulte.   

Abstract

Over the past decade MR (magnetic resonance) imaging has emerged as one of the major modalities for noninvasive functional imaging. Recent advances in the development of targeted MR contrast agents have added significantly to the capabilities of MR imaging. In particular, the use of targeted contrast agents to report on the expression of cell surface receptors, combined with the functional capabilities of MR imaging, together provide unique opportunities to understand receptor-mediated pathways. In this article we have reviewed current MRI strategies used to visualize receptor expression, the potential advantages and drawbacks of these strategies, and novel areas of focus for the future.

Mesh:

Substances:

Year:  2004        PMID: 15579038     DOI: 10.2174/1389201043376553

Source DB:  PubMed          Journal:  Curr Pharm Biotechnol        ISSN: 1389-2010            Impact factor:   2.837


  18 in total

1.  Magnetic resonance imaging detection of tumor cells by targeting low-density lipoprotein receptors with Gd-loaded low-density lipoprotein particles.

Authors:  Simonetta Geninatti Crich; Stefania Lanzardo; Diego Alberti; Simona Belfiore; Anna Ciampa; Giovanni B Giovenzana; Clara Lovazzano; Roberto Pagliarin; Silvio Aime
Journal:  Neoplasia       Date:  2007-12       Impact factor: 5.715

2.  Broadening the scope of image-guided radiotherapy (IGRT).

Authors:  Carlo Greco; C Clifton Ling
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

3.  Rational design of protein-based MRI contrast agents.

Authors:  Jenny J Yang; Jianhua Yang; Lixia Wei; Omar Zurkiya; Wei Yang; Shunyi Li; Jin Zou; Yubin Zhou; Anna L Wilkins Maniccia; Hui Mao; Fuqiang Zhao; Russell Malchow; Shumin Zhao; Julian Johnson; Xiaoping Hu; Eirik Krogstad; Zhi-Ren Liu
Journal:  J Am Chem Soc       Date:  2008-06-25       Impact factor: 15.419

4.  Use of a genetically engineered protein for the design of a multivalent MRI contrast agent.

Authors:  Lindsay S Karfeld; Steve R Bull; Nicolynn E Davis; Thomas J Meade; Annelise E Barron
Journal:  Bioconjug Chem       Date:  2007-10-10       Impact factor: 4.774

5.  Cardiovascular Imaging in Mice.

Authors:  Colin K L Phoon; Daniel H Turnbull
Journal:  Curr Protoc Mouse Biol       Date:  2016-03-01

6.  A fluorescent, paramagnetic and PEGylated gold/silica nanoparticle for MRI, CT and fluorescence imaging.

Authors:  Matti M van Schooneveld; David P Cormode; Rolf Koole; J Timon van Wijngaarden; Claudia Calcagno; Torjus Skajaa; Jan Hilhorst; Dannis C 't Hart; Zahi A Fayad; Willem J M Mulder; Andries Meijerink
Journal:  Contrast Media Mol Imaging       Date:  2010 Jul-Aug       Impact factor: 3.161

7.  Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents.

Authors:  Ian R Corbin; Hui Li; Juan Chen; Sissel Lund-Katz; Rong Zhou; Jerry D Glickson; Gang Zheng
Journal:  Neoplasia       Date:  2006-06       Impact factor: 5.715

8.  Multivalent protein polymer MRI contrast agents: controlling relaxivity via modulation of amino acid sequence.

Authors:  Lindsay S Karfeld-Sulzer; Emily A Waters; Nicolynn E Davis; Thomas J Meade; Annelise E Barron
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

9.  Imaging apolipoprotein AI in vivo.

Authors:  Renuka Sriram; Jens O Lagerstedt; Jitka Petrlova; Haris Samardzic; Ulrike Kreutzer; Hongtao Xie; George A Kaysen; Jean F Desreux; David Thonon; Vincent Jacques; Martha Van Loan; John C Rutledge; Michael N Oda; John C Voss; Thomas Jue
Journal:  NMR Biomed       Date:  2011-01-24       Impact factor: 4.044

10.  Strategies for Target-Specific Contrast Agents for Magnetic Resonance Imaging.

Authors:  Sashiprabha M Vithanarachchi; Matthew J Allen
Journal:  Curr Mol Imaging       Date:  2012-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.